» Articles » PMID: 32225120

Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Apr 1
PMID 32225120
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In the post-genome era, pathologies become associated with specific gene expression profiles and defined molecular lesions can be identified. The traditional therapeutic strategy is to block the identified aberrant biochemical activity. However, an attractive alternative could aim at antagonizing key transcriptional events underlying the pathogenesis, thereby blocking the consequences of a disorder, irrespective of the original biochemical nature. This approach, called transcription therapy, is now rendered possible by major advances in biophysical technologies. In the last two decades, techniques have evolved to become key components of drug discovery platforms, within pharmaceutical companies as well as academic laboratories. This review outlines the current biophysical strategies for transcription manipulation and provides examples of successful applications. It also provides insights into the future development of biophysical methods in drug discovery and personalized medicine.

Citing Articles

Evaluation of Synthetic 2,4-Disubstituted-benzo[]quinoxaline Derivatives as Potential Anticancer Agents.

Zaki I, Abu El-Ata S, Fayad E, Abu Ali O, Almaaty A, Saad A Pharmaceuticals (Basel). 2021; 14(9).

PMID: 34577556 PMC: 8466781. DOI: 10.3390/ph14090853.


Dissecting Transcription Factor-Target Interaction in Bovine Coronavirus Infection.

Morenikeji O, Strutton E, Wallace M, Bernard K, Yip E, Thomas B Microorganisms. 2020; 8(9).

PMID: 32872640 PMC: 7564962. DOI: 10.3390/microorganisms8091323.


Identifying Cattle Breed-Specific Partner Choice of Transcription Factors during the African Trypanosomiasis Disease Progression Using Bioinformatics Analysis.

Rajavel A, Heinrich F, Schmitt A, Gultas M Vaccines (Basel). 2020; 8(2).

PMID: 32456126 PMC: 7350023. DOI: 10.3390/vaccines8020246.

References
1.
Fujita-Yamaguchi Y . Affinity Chromatography of Native and Recombinant Proteins from Receptors for Insulin and IGF-I to Recombinant Single Chain Antibodies. Front Endocrinol (Lausanne). 2015; 6:166. PMC: 4621480. DOI: 10.3389/fendo.2015.00166. View

2.
Fordyce P, Gerber D, Tran D, Zheng J, Li H, DeRisi J . De novo identification and biophysical characterization of transcription-factor binding sites with microfluidic affinity analysis. Nat Biotechnol. 2010; 28(9):970-5. PMC: 2937095. DOI: 10.1038/nbt.1675. View

3.
Klaus M, Prokoph N, Girbig M, Wang X, Huang Y, Srivastava Y . Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction. Nucleic Acids Res. 2016; 44(8):3922-35. PMC: 4856986. DOI: 10.1093/nar/gkw130. View

4.
Kiessling A, Wiesinger R, Sperl B, Berg T . Selective inhibition of c-Myc/Max dimerization by a pyrazolo[1,5-a]pyrimidine. ChemMedChem. 2007; 2(5):627-30. DOI: 10.1002/cmdc.200600294. View

5.
Aggarwal B, Sethi G, Ahn K, Sandur S, Pandey M, Kunnumakkara A . Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2007; 1091:151-69. DOI: 10.1196/annals.1378.063. View